HEADER VIRAL PROTEIN/IMMUNE SYSTEM 22-OCT-10 2XV6 TITLE CRYSTAL STRUCTURE OF THE HIV-1 CAPSID PROTEIN C-TERMINAL DOMAIN (146- TITLE 2 220) IN COMPLEX WITH A CAMELID VHH. COMPND MOL_ID: 1; COMPND 2 MOLECULE: CAPSID PROTEIN P24; COMPND 3 CHAIN: A, C; COMPND 4 FRAGMENT: C-TERMINAL DOMAIN, RESIDUES 278-352; COMPND 5 SYNONYM: HIV-1 CAPSID PROTEIN; COMPND 6 ENGINEERED: YES; COMPND 7 MOL_ID: 2; COMPND 8 MOLECULE: CAMELID VHH 9; COMPND 9 CHAIN: B, D; COMPND 10 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HUMAN IMMUNODEFICIENCY VIRUS 1; SOURCE 3 ORGANISM_COMMON: HIV-1; SOURCE 4 ORGANISM_TAXID: 11676; SOURCE 5 STRAIN: NL4-3; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 9 EXPRESSION_SYSTEM_VARIANT: CODONPLUS-RIL; SOURCE 10 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 11 EXPRESSION_SYSTEM_PLASMID: PET11C; SOURCE 12 MOL_ID: 2; SOURCE 13 ORGANISM_SCIENTIFIC: VICUGNA PACOS; SOURCE 14 ORGANISM_COMMON: ALPACA; SOURCE 15 ORGANISM_TAXID: 30538; SOURCE 16 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 17 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 18 EXPRESSION_SYSTEM_STRAIN: BL21(DE3) KEYWDS VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR S.IGONET,M.C.VANEY,V.BARTONOVA,J.HELMA,U.ROTHBAUER,H.LEONHARDT, AUTHOR 2 E.STURA,H.-G.KRAUSSLICH,F.A.REY REVDAT 2 14-AUG-19 2XV6 1 AUTHOR JRNL REVDAT 1 12-OCT-11 2XV6 0 JRNL AUTH S.IGONET,M.C.VANEY,V.BARTONOVA,J.HELMA,U.ROTHBAUER, JRNL AUTH 2 H.LEONHARDT,E.STURA,H.-G.KRAUSSLICH,F.A.REY JRNL TITL TARGETING HIV-1 VIRION FORMATION WITH NANOBODIES JRNL TITL 2 -IMPLICATIONS FOR THE DESIGN OF ASSEMBLY INHIBITORS JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 1.89 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER 2.9.3 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.89 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 37.34 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 98.4 REMARK 3 NUMBER OF REFLECTIONS : 30838 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.176 REMARK 3 R VALUE (WORKING SET) : 0.175 REMARK 3 FREE R VALUE : 0.195 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.070 REMARK 3 FREE R VALUE TEST SET COUNT : 1563 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 15 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 1.89 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 1.96 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 98.36 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 2657 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.1811 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2529 REMARK 3 BIN R VALUE (WORKING SET) : 0.1786 REMARK 3 BIN FREE R VALUE : 0.2284 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 4.82 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 128 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2842 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 0 REMARK 3 SOLVENT ATOMS : 333 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 23.83 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 27.29 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.36110 REMARK 3 B22 (A**2) : -0.04010 REMARK 3 B33 (A**2) : -0.32100 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.09960 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.182 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : 0.149 REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.123 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.140 REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : 0.119 REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.947 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.940 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 2916 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 3940 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 1038 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : 77 ; 2.000 ; HARMONIC REMARK 3 GENERAL PLANES : 424 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 2916 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 381 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 3600 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 BOND ANGLES (DEGREES) : 1.01 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 3.20 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 16.13 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: THE 6XHISTIDINE TAG AT THE C-TERMINUS REMARK 3 IS DISORDERED. REMARK 4 REMARK 4 2XV6 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 22-OCT-10. REMARK 100 THE DEPOSITION ID IS D_1290045846. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 01-NOV-08 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 5 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SLS REMARK 200 BEAMLINE : X06SA REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.99 REMARK 200 MONOCHROMATOR : SI(111) MONOCHROMATOR REMARK 200 OPTICS : DYNAMICALLY BENDABLE MIRROR REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 42152 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.690 REMARK 200 RESOLUTION RANGE LOW (A) : 47.630 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 97.2 REMARK 200 DATA REDUNDANCY : 3.200 REMARK 200 R MERGE (I) : 0.04000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 15.0000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.69 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.78 REMARK 200 COMPLETENESS FOR SHELL (%) : 82.8 REMARK 200 DATA REDUNDANCY IN SHELL : 2.20 REMARK 200 R MERGE FOR SHELL (I) : 0.31000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.600 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: PDB ENTRY 2XT1 REMARK 200 REMARK 200 REMARK: NONE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 45.97 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.09 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 30% PEG 4000 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 30.05900 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 1540 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 9240 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -8.6 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: C, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 1640 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 9650 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -7.4 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET B -1 REMARK 465 HIS B 114 REMARK 465 HIS B 115 REMARK 465 HIS B 116 REMARK 465 HIS B 117 REMARK 465 HIS B 118 REMARK 465 HIS B 119 REMARK 465 SER C 146 REMARK 465 PRO C 147 REMARK 465 GLY C 206 REMARK 465 PRO C 207 REMARK 465 GLY C 208 REMARK 465 GLN C 219 REMARK 465 GLY C 220 REMARK 465 MET D -1 REMARK 465 ALA D 0 REMARK 465 HIS D 114 REMARK 465 HIS D 115 REMARK 465 HIS D 116 REMARK 465 HIS D 117 REMARK 465 HIS D 118 REMARK 465 HIS D 119 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 O HOH A 2070 O HOH B 2015 2455 0.43 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 CYS B 92 CB CYS B 92 SG -0.107 REMARK 500 CYS C 218 CB CYS C 218 SG -0.110 REMARK 500 CYS D 92 CB CYS D 92 SG -0.100 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLN B 1 -71.96 -153.64 REMARK 500 ALA B 24 80.96 -163.37 REMARK 500 ALA D 24 78.06 -152.12 REMARK 500 ALA D 88 169.70 177.25 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 GLN D 1 VAL D 2 142.78 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A2080 DISTANCE = 6.67 ANGSTROMS REMARK 525 HOH B2100 DISTANCE = 7.17 ANGSTROMS REMARK 525 HOH B2101 DISTANCE = 5.87 ANGSTROMS REMARK 525 HOH D2097 DISTANCE = 5.82 ANGSTROMS REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 2XXM RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE HIV-1 CAPSID PROTEIN C- TERMINAL DOMAIN IN REMARK 900 COMPLEX WITH A CAMELID VHH AND THE CAI PEPTIDE. REMARK 900 RELATED ID: 2XT1 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE HIV-1 CAPSID PROTEIN C- TERMINAL DOMAIN REMARK 900 (146-231) IN COMPLEX WITH A CAMELID VHH. REMARK 900 RELATED ID: 2XXC RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF A CAMELID VHH RAISED AGAINST THE HIV-1 CAPSID REMARK 900 PROTEIN C-TERMINAL DOMAIN. REMARK 999 REMARK 999 SEQUENCE REMARK 999 THE VHH RESIDUES (CHAIN B AND D) ARE NUMBERED ACCORDING TO REMARK 999 THE KABAT NUMBERING. 6XHISTIDINE C-TERMINAL EXPRESSION TAG. DBREF 2XV6 A 146 220 UNP P12497 POL_HV1N5 278 352 DBREF 2XV6 B -1 119 PDB 2XV6 2XV6 -1 119 DBREF 2XV6 C 146 220 UNP P12497 POL_HV1N5 278 352 DBREF 2XV6 D -1 119 PDB 2XV6 2XV6 -1 119 SEQRES 1 A 75 SER PRO THR SER ILE LEU ASP ILE ARG GLN GLY PRO LYS SEQRES 2 A 75 GLU PRO PHE ARG ASP TYR VAL ASP ARG PHE TYR LYS THR SEQRES 3 A 75 LEU ARG ALA GLU GLN ALA SER GLN GLU VAL LYS ASN TRP SEQRES 4 A 75 MET THR GLU THR LEU LEU VAL GLN ASN ALA ASN PRO ASP SEQRES 5 A 75 CYS LYS THR ILE LEU LYS ALA LEU GLY PRO GLY ALA THR SEQRES 6 A 75 LEU GLU GLU MET MET THR ALA CYS GLN GLY SEQRES 1 B 121 MET ALA GLN VAL GLN LEU VAL GLU SER GLY GLY GLY LEU SEQRES 2 B 121 VAL GLN ALA GLY GLY SER LEU ARG LEU SER CYS ALA ALA SEQRES 3 B 121 SER GLY SER PHE PHE MET SER ASN VAL MET ALA TRP TYR SEQRES 4 B 121 ARG GLN ALA PRO GLY LYS ALA ARG GLU LEU ILE ALA ALA SEQRES 5 B 121 ILE ARG GLY GLY ASP MET SER THR VAL TYR ASP ASP SER SEQRES 6 B 121 VAL LYS GLY ARG PHE THR ILE THR ARG ASP ASP ASP LYS SEQRES 7 B 121 ASN ILE LEU TYR LEU GLN MET ASN ASP LEU LYS PRO GLU SEQRES 8 B 121 ASP THR ALA MET TYR TYR CYS LYS ALA SER GLY SER SER SEQRES 9 B 121 TRP GLY GLN GLY THR GLN VAL THR VAL SER SER HIS HIS SEQRES 10 B 121 HIS HIS HIS HIS SEQRES 1 C 75 SER PRO THR SER ILE LEU ASP ILE ARG GLN GLY PRO LYS SEQRES 2 C 75 GLU PRO PHE ARG ASP TYR VAL ASP ARG PHE TYR LYS THR SEQRES 3 C 75 LEU ARG ALA GLU GLN ALA SER GLN GLU VAL LYS ASN TRP SEQRES 4 C 75 MET THR GLU THR LEU LEU VAL GLN ASN ALA ASN PRO ASP SEQRES 5 C 75 CYS LYS THR ILE LEU LYS ALA LEU GLY PRO GLY ALA THR SEQRES 6 C 75 LEU GLU GLU MET MET THR ALA CYS GLN GLY SEQRES 1 D 121 MET ALA GLN VAL GLN LEU VAL GLU SER GLY GLY GLY LEU SEQRES 2 D 121 VAL GLN ALA GLY GLY SER LEU ARG LEU SER CYS ALA ALA SEQRES 3 D 121 SER GLY SER PHE PHE MET SER ASN VAL MET ALA TRP TYR SEQRES 4 D 121 ARG GLN ALA PRO GLY LYS ALA ARG GLU LEU ILE ALA ALA SEQRES 5 D 121 ILE ARG GLY GLY ASP MET SER THR VAL TYR ASP ASP SER SEQRES 6 D 121 VAL LYS GLY ARG PHE THR ILE THR ARG ASP ASP ASP LYS SEQRES 7 D 121 ASN ILE LEU TYR LEU GLN MET ASN ASP LEU LYS PRO GLU SEQRES 8 D 121 ASP THR ALA MET TYR TYR CYS LYS ALA SER GLY SER SER SEQRES 9 D 121 TRP GLY GLN GLY THR GLN VAL THR VAL SER SER HIS HIS SEQRES 10 D 121 HIS HIS HIS HIS FORMUL 5 HOH *333(H2 O) HELIX 1 1 SER A 149 ILE A 153 5 5 HELIX 2 2 PRO A 160 GLU A 175 1 16 HELIX 3 3 SER A 178 LEU A 190 1 13 HELIX 4 4 ASN A 195 GLY A 206 1 12 HELIX 5 5 THR A 210 CYS A 218 1 9 HELIX 6 6 ASP B 61 LYS B 64 5 4 HELIX 7 7 LYS B 83 THR B 87 5 5 HELIX 8 8 SER C 149 ILE C 153 5 5 HELIX 9 9 PRO C 160 GLU C 175 1 16 HELIX 10 10 SER C 178 LEU C 190 1 13 HELIX 11 11 ASN C 195 LEU C 205 1 11 HELIX 12 12 THR C 210 CYS C 218 1 9 HELIX 13 13 ASP D 61 LYS D 64 5 4 HELIX 14 14 LYS D 83 THR D 87 5 5 SHEET 1 BA 4 VAL B 5 SER B 7 0 SHEET 2 BA 4 LEU B 18 ALA B 23 -1 O SER B 21 N SER B 7 SHEET 3 BA 4 ILE B 77 MET B 82 -1 O LEU B 78 N CYS B 22 SHEET 4 BA 4 PHE B 67 ASP B 72 -1 O THR B 68 N GLN B 81 SHEET 1 BB12 SER B 56 TYR B 59 0 SHEET 2 BB12 GLU B 46 ARG B 52 -1 O ALA B 50 N VAL B 58 SHEET 3 BB12 VAL B 33 GLN B 39 -1 O MET B 34 N ILE B 51 SHEET 4 BB12 ALA B 88 ALA B 94 -1 O MET B 89 N GLN B 39 SHEET 5 BB12 THR B 107 SER B 112 -1 O THR B 107 N TYR B 90 SHEET 6 BB12 GLY B 10 GLN B 13 1 O GLY B 10 N THR B 110 SHEET 7 BB12 GLY D 10 GLN D 13 -1 O LEU D 11 N LEU B 11 SHEET 8 BB12 THR D 107 SER D 112 1 O GLN D 108 N GLY D 10 SHEET 9 BB12 ALA D 88 ALA D 94 -1 O ALA D 88 N VAL D 109 SHEET 10 BB12 VAL D 33 GLN D 39 -1 O ALA D 35 N LYS D 93 SHEET 11 BB12 GLU D 46 ARG D 52 -1 O GLU D 46 N ARG D 38 SHEET 12 BB12 THR D 57 TYR D 59 -1 O VAL D 58 N ALA D 50 SHEET 1 DA 4 VAL D 5 SER D 7 0 SHEET 2 DA 4 LEU D 18 ALA D 23 -1 O SER D 21 N SER D 7 SHEET 3 DA 4 ILE D 77 MET D 82 -1 O LEU D 78 N CYS D 22 SHEET 4 DA 4 PHE D 67 ASP D 72 -1 O THR D 68 N GLN D 81 SSBOND 1 CYS B 22 CYS B 92 1555 1555 2.15 SSBOND 2 CYS D 22 CYS D 92 1555 1555 2.21 CISPEP 1 SER A 146 PRO A 147 0 -1.41 CRYST1 34.451 60.118 96.662 90.00 99.70 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.029027 0.000000 0.004962 0.00000 SCALE2 0.000000 0.016634 0.000000 0.00000 SCALE3 0.000000 0.000000 0.010495 0.00000